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The divalent cation zinc is found in the mammalian CNS
either tightly bound to proteins or as a smaller pool of free,
chelatable zinc (Cuajungco and Lees 1997; Zatta et al.
2003). Genetic deletion of the zinc transporter ZnT3 in mice
results in a dramatic decrease in the amount of zinc that can
be detected in synaptic terminals but produces no obvious
change in the behavior of mice (Palmiter et al. 1996; Cole
et al. 1999; Salazar et al. 2005). Despite this observation,
there is considerable evidence in support of the idea that
synaptically released zinc plays a role as a regulator of
synaptic transmission in the brain (Li et al. 2003). The most
direct in vivo evidence for zinc as a physiological modulator
in the brain is the observation that mice that express a mutant
form of the glycine receptor a1 subunit gene (Glra1) that is
zinc insensitive, but fully responsive to glycine, show a
dramatic startle-prone phenotype, hyperekplexia (Hirzel
et al. 2006).
In addition to modulating the activity of glycine receptors
in vivo, in vitro studies indicate that extracellular zinc can
potentiate or inhibit the current responses of nicotinic
acetylcholine receptors (Hsiao et al. 2001, 2006), N-
methyl-D-aspartate receptors (Forsythe et al. 1988; Rassen-
dren et al. 1990) and GABA type A receptors (Gibbs et al.
2000). It has also been shown that zinc potentiates ATP-
activated currents in many cell types including rat sympa-
thetic neurons (Cloues et al. 1993), rat nodose ganglion
neurons (Wright and Li 1995), and acutely isolated rat
hypothalamic neurons (Vorobjev et al. 2003). ATP released
from cells can function as a synaptic neurotransmitter, an
autocrine signal, or a paracrine signal in a wide range of
mammalian tissues (Ralevic and Burnstock 1998; Stojilkovic
and Koshimizu 2001). This signaling is mediated by
ionotropic P2X receptors (P2XRs) and G protein-coupled
P2Y receptors. Because ATP and zinc are both released from
some neurons in an activity-dependent manner (Wright and
Li 1995), it is plausible that neurotransmission at P2X
utilizing synapses is modulated in vivo by zinc.
The P2X receptor family consists of seven genes (P2X1-
X7) and the proteins they encode function as homomeric or
heteromeric oligomers of three subunits (North 2002). Each
P2X subunit has a short intracellular amino terminus, a first
transmembrane domain, a large extracellular domain, a
second transmembrane domain and a carboxy terminal
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Abstract
Two histidines are known to be essential for zinc potentiation
of rat P2X2 receptors, but the chemistry of zinc coordination
would suggest that other residues also participate in this zinc-
binding site. There is also a second lower affinity zinc-binding
site in P2X2 receptors whose constituents are unknown. To
assess whether the extracellular acidic residues of the P2X2
receptor contribute to zinc potentiation or inhibition, site-di-
rected mutagenesis was used to produce alanine substitutions
at each extracellular glutamate or aspartate. Two electrode
voltage clamp recordings from Xenopus oocytes indicated that
7 of the 34 mutants (D82A, E85A, E91A, E115A, D136A,
D209A, and D281A) were deficient in zinc potentiation and
one mutant (E84A) was deficient in zinc inhibition. Additional
tests on cysteine mutants at these eight positions indicated
that D136 is the only residue that is a strong candidate to be at
the potentiating zinc-binding site, and that E84 is unlikely to be
at the inhibitory zinc-binding site.
Keywords: MTSES, MTSET, P2X receptors, substituted-
cysteine accessibility, zinc modulation.
J. Neurochem. (2008) 105, 1264–1275.
d JOURNAL OF NEUROCHEMISTRY | 2008 | 105 | 1264–1275 doi: 10.1111/j.1471-4159.2008.05228.x
1264 Journal Compilation  2008 International Society for Neurochemistry, J. Neurochem. (2008) 105, 1264–1275
 2008 The Authors
domain of diverse length among subunits (Fig. 1). With
respect to P2X2 receptors, zinc exerts a concentration-
dependent biphasic modulation that is thought to result from
an increase in ATP affinity at low concentrations of zinc,
and a voltage-independent inhibition that reduces the
efficacy of channel opening at high concentrations of zinc
(Wildman et al. 1998; Clyne et al. 2002a; Vorobjev et al.
2003). It has been shown previously by alanine-scanning
mutagenesis that two extracellular histidines, H120 and
H213, are required for zinc potentiation of P2X2 (Clyne
et al. 2002a). Furthermore, the coordination of zinc by
P2X2 has been shown to occur at the interface between
adjacent subunits (Nagaya et al. 2005). Prior studies on zinc
finger transcription factors and metalloenzymes have shown
that zinc is typically coordinated in a tetrahedral configu-
ration that requires nitrogen, oxygen, and sulfur ligands
from the side chains of histidine, aspartate, glutamate, or
cysteine residues (Maret 2005). All the extracellular histi-
dines (Clyne et al. 2002a) and cysteines (Clyne et al.
2002b) of P2X2 have already been tested for their potential
role in zinc potentiation. Therefore, in the current study, we
tested whether negatively charged residues of the P2X2
extracellular domain are structural determinants of the
excitatory and/or inhibitory zinc-binding sites.
Experimental procedures
Mutagenesis
Rat P2X2 cDNA (encoding a 472-amino acid protein) in pcDNA1
was obtained from Dr D. Julius (University of California, San
Francisco, CA, USA). The mutations were generated using the
QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA,
USA). The sequences of mutant subunits were confirmed by DNA
sequencing (University of Michigan DNA Sequencing Core). Each











































Fig. 1 Residues of the extracellular domain
of P2X2 tested in this study. P2X2 receptors
function as homotrimers. The full length of
one of the subunits (black) is shown with
pieces of the two neighboring subunits
(gray) that contribute to the intersubunit
coordination of zinc at the potentiating site.
All of the negative residues in the extracel-
lular region are numbered in accord with the
rat P2X2 sequence. Within the extracellular
domain aspartate residues are shown in
cyan, and glutamate residues are shown in
red. D or E residues with black outlines are
conserved in at least six of the seven rat
P2X receptors. The two extracellular histi-
dines (H120 and H213) known to coordi-
nate zinc between subunits at the site for
potentiation are shown in yellow. The seven
other extracellular histidines are not shown.
With the exception of the histidines that
bind zinc and the 10 conserved extracellular
cysteines that are believed to form five
disulfide bonds (dashed lines), the relative
positions of residues is unknown, so resi-
dues quite far apart in this schematic dia-
gram might be physically quite close.
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followed by the residue number and the substituted amino acid (one-
letter code).
Expression of P2X2 receptors
P2X2 receptors were expressed in defolliculated stage V-VI Xenopus
laevis oocytes. Oocytes were harvested using procedures approved
by the University of Michigan Committee on the Use and Care of
Vertebrate Animals and have been described in detail previously
(Zhou and Hume 1998). RNAs encoding wild-type and mutant
P2X2 receptors were synthesized using the mMessage mMachine T7
kit (Ambion, Austin, TX, USA). Each oocyte was injected with
50 nL of RNA at 100–150 ng/lL, concentrations that produce a
maximal response in wild-type P2X2 (Clyne et al. 2003).
Electrophysiological recordings
Two-electrode voltage clamp experiments were performed 2–5 days
after RNA injection. All of the recordings were made at a holding
potential of )50 mV. Recording electrodes were pulled from thin-
walled borosilicate glass on a model P-87 Flaming Brown puller
(Sutter Instrument Company, Novato, CA, USA) and had resistances
of 0.5–1 MW. The currents were recorded with a Turbo TEC-03
voltage clamp amplifier (npi electronic GmBH, Tamm, Germany).
Data acquisition was performed using a Digidata 1322A interface
controlled by pCLAMP 9 (Molecular Devices, Union City, CA,
USA).
Materials
[2-(trimethylammonium) ethyl] methanethiosulfonate bromide
(MTSET) and sodium (2-sulfonatoethyl) methane thiosulfonate
(MTSES) were obtained from Toronto Research Chemicals (North
York, ON, USA). All other chemicals were obtained from Sigma
Life Sciences (St. Louis, MO, USA).
Solutions
The external recording solution contained (in mM): 90 NaCl, 1 KCl,
1.3 MgCl2, and 10 HEPES, pH 7.5. Electrodes were filled with an
internal solution of 3 M KCl. Disodium ATP was prepared as a
100 mM stock in double-distilled H2O and stored at )20C. For
recording, ATP solutions were made by diluting the stock in external
recording solution. ATP solutions with concentrations of 200 lM
and above were supplemented with MgCl2 to account for chelation
of Mg2+ by ATP. The amount to add to each concentration of ATP
was calculated using Bound and Determined (Brooks and Storey
1992) so that the free magnesium concentration was 1 mM. The
ATP concentrations of recording solutions were verified by
spectroscopic measurement at 259 nm (using an extinction coeffi-
cient of 15.4 · 103 M)1 cm)1). Zinc chloride was prepared as a
100 mM stock in double-distilled H2O that was acidified with
0.01 M HCl to prevent precipitation. The pH of ATP solutions with
and without zinc was adjusted to 7.5 prior to recording. For
experiments assaying pH potentiation, the pH of ATP solutions to be
tested was adjusted to 6.5 prior to recording. All ATP recording
solutions were used within 48 h.
The sulfhydryl-reactive reagents MTSET and MTSES were
prepared as 1 M stocks in dimethyl sulfoxide and stored in 10-lL
aliquots at )20C. For recording, the stocks were diluted in the
standard HEPES-buffered external recording solution to a working
concentration of 1 or 10 mM. For each incubation, 50 lL of the
working solution was added to the recording chamber with flow
through the chamber stopped. After incubation for 1–2 min, the
oocytes were washed in external recording solution for 1 min, and
then assayed with the same protocol used before treatment. This was
repeated until there was no further change in response.
Quantification of zinc modulation and selection of zinc and ATP
concentrations
The response of P2X2 receptors to zinc is biphasic; at low levels,
zinc causes potentiation, but at high levels it results in inhibition of
current (Wildman et al. 1998). In a previous study, we used the non-
potentiating mutants H120A and H213A to demonstrate that these
two effects of zinc are separate processes. At a zinc concentration of
20 lM or below, the inhibition is negligible, whereas at all higher
zinc concentrations both processes are occurring (Clyne et al.
2002a). We therefore used 20 lM zinc in all experiments testing
only zinc potentiation, even though 50 and 100 lM zinc produce
greater potentiation.
To compare the magnitude of zinc potentiation between groups of
oocytes, it is essential that all of the oocytes be studied at similar
points on the ATP concentration response relation, because as the
concentration of ATP increases, potentiation decreases so that there is
no zinc potentiation when a saturating concentration of ATP is
present (Wildman et al. 1998). Furthermore, the EC50 for ATP of
different oocytes expressing the same construct can vary significantly
(Clyne et al. 2003). We dealt with these complications by testing
each oocyte with both a low concentration of ATP which we expected
would be close to the EC10 based on the average concentration
response relation for each construct, and with 1000 lM ATP, a
maximal concentration for all constructs used in this study. Only data
from oocytes for which it was verified that the low ATP concentration
used was between the EC5 and the EC15 (so that at least a sixfold
increase in current was possible) were analyzed. All currents were
measured after the responses had come to a steady state.
To test for zinc potentiation, oocytes were given low ATP
followed by low ATP plus 20 lM zinc. We defined potentiation to
20 lM zinc as [(current in low ATP plus 20 lM zinc/current in low
ATP) -1]. Thus, a cell that showed no increase in current in response
to zinc had zinc potentiation equal to 0, and a cell inhibited by
20 lM zinc had negative zinc potentiation.
To test for zinc inhibition, oocytes were given low ATP plus
20 lM zinc followed by low ATP plus 1000 lM zinc. We defined
zinc inhibition as [1-(current in low ATP with 1000 lM zinc/current
in low ATP with 20 lM zinc)]%. Thus, a construct in which high
zinc completely inhibited the response would have an inhibition
index of 100%, a construct unresponsive to high zinc would have
0% inhibition, and a construct in which 1000 lM zinc potentiated
more than 20 lM zinc would have negative inhibition.
Data analysis
Data were analyzed using Clampfit and Microsoft Excel. Error bars
shown in all figures are the standard error of the mean (SEM). The
significance of differences between experimental conditions was
tested using the student’s t-test function of Excel. When the same
oocyte was tested before and after some treatment, the paired t-test
was used, while when groups of oocytes were compared with each
other the unpaired t-test was used. To minimize the possibility that
with so many mutants compared to the wild-type apparent
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significance might arise based on chance alone, significance was
taken to be p < 0.01.
Concentration–response relations for ATP were fit to the three
parameter Hill equation using the nonlinear curve fitting program of
Sigmaplot 9.0 (Systat Software Inc., San Jose, CA, USA). For
displaying average concentration response data, the points from
each oocyte were normalized to between 0% and 100% based on the
maximum value of the fitted curve. The scaled data were then
averaged and plotted with error bars indicating the standard error of
the mean. The lines fit to the data indicate the average parameters of
the individual fits.
Results
When voltage clamped at )50 mV, oocytes expressing all 34
of the P2X2 mutants tested (Fig. 1) responded to 100 lM
ATP with readily detectable inward currents. Concentration–
response relations were assessed by giving an ascending
series of ATP concentrations without intervening washes
(Fig. 2a and b), and the data were fit to the Hill equation
(Fig. 2c). All shifts in the EC50 were < 10-fold (Table 1).
The mutant receptor E85A showed the greatest rightward
shift in EC50 (about fivefold), and the mutant receptor
D315A showed the greatest leftward shift in EC50 (about 6.5-
fold, Fig. 2b). In addition to changes in EC50, some mutants
showed Hill coefficients that were somewhat larger or
smaller than wild-type. We did not explore the mechanisms
that caused these changes because there was no apparent
correlation between having an altered Hill coefficient or EC50
and having a change in the ability to respond to zinc
(Table 1). To determine the maximum response that each
construct could produce when saturating levels of RNAwere
injected, we used 1000 lM ATP, which is maximal for all
mutants studied. All mutants had maximal currents of at least
)3 lA (Table 1), indicating that several million functional
receptors were successfully delivered to the cell surface.
Zinc potentiation was assayed (Fig. 3a) and quantified as
described in Experimental procedures. Wild-type P2X2
exhibited mean zinc potentiation of about 7 while the zinc
insensitive mutations previously studied (H120A and
H213A) gave potentiation near 0. All 34 mutants tested in
this study gave detectable zinc potentiation (Fig. 3b). None of
the mutants showed a significant increase in zinc potentiation.
Five mutants (D82A, E85A, E91A, D136A, and D209A), all
with an average zinc potentiation below 3, potentiated
significantly less (p < 0.01) than wild-type P2X2. Two other
mutants (E115A and D281A) had error bars that extended
below 3 and just missed passing our test of significance (with
p < 0.015 but not <0.01). We focused the rest of our studies
of zinc potentiation on these seven mutants.
In wild-type P2X2, the potentiation to zinc declines as zinc
concentration rises above 100 lM. This is due to the action
of a low affinity inhibitory site with an estimated IC50 of
about 120 lM (Clyne et al. 2002a). As a screen for whether
any of these mutations might have altered the inhibitory zinc-
binding site, we compared the amplitude of responses to the
EC10 concentration of ATP alone, the EC10 concentration of
ATP plus 20 lM zinc, the EC10 concentration of ATP plus
1000 lM zinc, and 1000 lM ATP (a saturating concentra-
tion) alone (Fig. 4a). The quantitative index of zinc inhibi-
tion (Fig. 4b) was calculated as defined in Experimental
procedures. For wild-type P2X2, the current declined about
fivefold as zinc was increased from 20 lM to 1000 lM, such
that the amplitude of responses to low ATP alone and low
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Fig. 2 Method for obtaining ATP concentration response relations. (a
and b) Representative traces illustrating concentration response
relationship of wild-type P2X2 receptors and the mutant D315A (the
most left-shifted mutant studied). The numbers in the boxes above
each trace indicate the ATP concentration in lM and the length of the
boxes indicates the duration of each application. All traces were ob-
tained from Xenopus oocytes voltage clamped at )50 mV. (c) Con-
centration–response relationships of oocytes expressing wild-type
P2X2 and D315A. The error bars represent the standard error of the
mean (SEM).
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mutants assayed, 25 exhibited no significant difference from
the 75% inhibition by 1000 lM zinc measured in wild-type
P2X2. Eight mutants, (E85A, E91A, E115A, D127A,
D136A, E167A, D172A, and D261) showed significantly
enhanced zinc inhibition (Fig 4b; p < 0.01), and one mutant
(E84A) showed significantly decreased zinc inhibition. An
increase in zinc inhibition is opposite to the result expected if
these residues were part of the inhibitory zinc-binding site. It
should be noted that when the combination of low ATP and
high zinc was applied or removed, currents of wild-type
P2X2 receptors showed transients at both the onset and the
offset (see Fig 4a). These transients are a manifestation of the
slower on-kinetics and faster off-kinetics of the low affinity
zinc inhibition as compared to the higher affinity zinc
Table 1 Characteristics of rat P2X2 recep-
tors and mutant receptors with an alanine












wild-type 15 ± 1.3 1.9 ± 0.05 12.8 ± 1.6 20
D57A 43 ± 9.9* 1.3 ± 0.21* 12.0 ± 1.4 6 4
E59A 10 ± 0.6 1.9 ± 0.08 9.8 ± 1.5 4 6
E63A 20 ± 6.9 1.0 ± 0.08* 3.1 ± 0.3 9 2
E77A 22 ± 1.0 1.7 ± 0.03 6.3 ± 1.4 5 1
D78A 33 ± 5.5* 1.6 ± 0.12 6.1 ± 1.0 5 2
D82A 55 ± 8.0* 1.1 ± 0.07* 9.6 ± 1.2 11 7
E84A 3 ± 0.2* 2.1 ± 0.09 16.7 ± 1.4 5 1
E85A 66 ± 5.2* 1.8 ± 0.09 7.3 ± 1.9 8 7
E91A 48 ± 6.6* 1.4 ± 0.03* 7.3 ± 0.4 5 1
E103A 7 ± 1.0* 1.9 ± 0.09 12.5 ± 1.5 6 1
E115A 42 ± 2.7* 1.5 ± 0.04 8.0 ± 0.7 5 7
D127A 12 ± 1.4 3.0 ± 0.55* 25.5 ± 5.3 9 7
D128A 35 ± 2.9 1.3 ± 0.06* 18.1 ± 1.4 6 3
D129A 20 ± 1.5 1.9 ± 0.07 23.0 ± 4.6 5 4
D136A 17 ± 3.6 2.0 ± 0.10 9.3 ± 1.5 6 4
D154A 9 ± 0.6 3.2 ± 0.64* 16.3 ± 1.6 5 1
E159A 9 ± 0.3* 4.1 ± 0.52* 16.1 ± 1.7 8 7
E167A 7 ± 0.3* 1.3 ± 0.16* 16.0 ± 3.2 5 7
D168A 20 ± 2.5 1.5 ± 0.11 24.8 ± 2.8 5 4
D172A 11 ± 0.6 1.7 ± 0.04 17.1 ± 2.4 5 2
D209A 43 ± 4.5* 1.5 ± 0.05* 9.1 ± 0.5 6 2
D217A 10 ± 0.5 2.1 ± 0.09 18.6 ± 2.2 5 2
D219A 10 ± 0.3 1.8 ± 0.06 15.1 ± 1.0 5 2
D221A 5 ± 0.7* 2.3 ± 0.10* 16.4 ± 3.2 6 2
E234A 15 ± 1.0 1.8 ± 0.13 15.3 ± 0.8 6 1
E238A 12 ± 1.4 1.5 ± 0.04* 20.8 ± 2.8 6 2
E242A 2 ± 0.2* 1.9 ± 0.05 18.5 ± 2.4 5 5
D259A 19 ± 3.0 1.7 ± 0.17 11.0 ± 1.8 5 4
D261A 9 ± 0.5* 2.0 ± 0.09 7.7 ± 0.8 8 7
E264A 8 ± 0.4* 2.3 ± 0.20* 17.9 ± 3.7 7 1
E266A 7 ± 0.4* 1.7 ± 0.09 18.2 ± 2.1 5 2
D277A 22 ± 4.2 1.2 ± 0.10* 11.6 ± 2.2 5 6
D281A 4 ± 0.3* 1.9 ± 0.04 12.7 ± 2.0 6 2
D315A 2 ± 0.4* 2.5 ± 0.45 26.6 ± 8.1 6 7
Values reported are the mean and the SEM for each construct tested. N indicates the number of
oocytes tested to determine the concentration–response relation. Data from additional oocytes
were sometimes included in estimates of the maximal current. The seven mutants with significantly
decreased zinc potentiation (five with p < 0.01 plus two additional mutants that differed from wild-
type at p < 0.015) are indicated with light gray shading, and the one mutant with significantly
decreased zinc inhibition is indicated with dark gray shading. Asterisks indicate EC50s or Hill
coefficients that were significantly different from wild-type P2X2 (p < 0.01, two-tailed t-test
assuming equal variance).
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potentiation process (Clyne et al. 2002a). The on and off
transients were much larger in the currents of the E84A
mutant (Fig. 4a).
The decrease in either potentiation to low zinc (20 lM) or
inhibition to high zinc (1000 lM) might reflect an impeded
ability to bind zinc at the modulatory sites, a diminution of
communication between the occupied zinc-binding site and
the gating machinery, enhanced opposing modulation, or a
general defect in channel gating. In the latter case, these
candidate mutants might have been expected to also be
deficient in potentiation to protons, an allosteric modulator
(Nakazawa et al. 1997) that acts at a different site (Clyne
et al. 2002a). In wild-type receptors, application of an ATP
concentration that produced an EC10 response at pH 7.5
produced a large increase in current when the pH was
dropped to 6.5. Each of the mutants that were highly
deficient in zinc potentiation or inhibition had pH potenti-
ation that was indistinguishable from wild-type P2X2 (wild-
type 6.3 ± 1.1, D82A 6.2 ± 0.7, E84A 8.4 ± 1.3, D85A
7.0 ± 0.8, E91A 6.1 ± 0.5, E115A 6.2 ± 0.8, D136A 5.4 ±
1.0, D209A 6.9 ± 0.7, D281A 7.2 ± 1.5), so none of these
mutations produced a general defect in channel gating.
Cysteines support greater zinc potentiation than alanines
at several candidate sites
To test the role of amino acid residues identified in the
alanine screen, we generated individual cysteine substitutions
at the candidate positions and determined their effects on
zinc potentiation and inhibition. If a candidate residue
participates in zinc-binding, it would be expected that the
response to zinc would be enhanced in the ‘C’ version over
the ‘A’ version, because it is known that cysteine residues
perform better than non-polar alanine residues as ligands for
zinc (Maret 2005). Responses to ATP were recorded from all
the cysteine-substituted candidates. Cysteine substitution
increased zinc potentiation over alanine substitution at
positions 82, 136, and 209. There was no significant
difference between zinc potentiation for A and C mutants
at positions 84, 85, 91, and 281, and a cysteine at position
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Fig. 3 Potentiation of wild-type and mutant P2X2 receptors by
20 lM zinc. (a) Representative traces from wild-type P2X2 and each
mutant receptor that was deficient in zinc potentiation. Each con-
struct was first tested with an amount of ATP that produced
approximately 10% of the maximal response (EC10 ATP), then with
EC10 ATP plus 20 lM zinc, and finally with 1000 lM ATP. All traces
were scaled so that the response to 1000 lM ATP was of equal
height. The current in response to this concentration of ATP pro-
duced a maximal response for all constructs. The dotted line across
all the traces represents the predicted amplitude of the current if zinc
potentiation was unchanged. The dashed line intersecting each trace
indicates the actual amount of zinc potentiation. (b) Potentiation in
response to 20 lM zinc for all mutants studied. Zinc potentiation was
calculated as defined in Experimental procedures. The dashed line
indicates a potentiation ratio of 3.0. For each construct, data from
5–10 oocytes were averaged. Error bars represent the SEM. Black
bars indicate mutants that showed significantly reduced zinc poten-
tiation (p < 0.01) compared to wild-type P2X2. Two additional
mutants, E115A and D281A differed from wild-type at p < 0.015 and
are indicated with diagonal lines.
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To test whether any of the cysteine-substituted zinc
modulation candidates were accessible to the positively
charged, thiol-reactive compound MTSET (Javitch et al.
1994), oocytes expressing the cysteine-substituted candidates
were assayed for zinc potentiation or inhibition before and
after treatment with MTSET. For a positive control to verify
P2X2
E84A
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EC10 ATP
+ 20 µM zinc
EC10 ATP
+ 1000 µM zinc
(a)
(b)
Fig. 4 Inhibition of wild-type and mutant P2X2 receptors by 1000 lM
zinc. (a) Examples of inhibition by high zinc in wild-type P2X2 and in
mutants that showed less inhibition (E84A) and enhanced inhibition
(D172A). Each trace is the response as the bathing solution was
switched from external solution alone to the indicated solutions for the
duration indicated by the bar. Five minutes of recovery was allowed
between adjacent traces. Zinc inhibition was determined based on the
amplitude of the current with EC10 ATP + 1000 lM zinc (dashed line)
and the current with EC10 ATP + 20 lM zinc (solid line). (b) Inhibition
in response to 1,000 lM zinc for all mutants studied. Zinc inhibition
was calculated as defined in Experimental procedures, with 100%
representing complete inhibition, and 0% representing no inhibition.
The dashed line indicates 50% inhibition. For each construct, data
from 3–10 oocytes were averaged. Error bars represent the SEM. The
black bar indicates the one mutant that showed significantly reduced
zinc inhibition (p < 0.01) compared to wild-type P2X2. Asterisks indi-
cate mutants that showed significantly increased zinc inhibition
(p < 0.01) compared to wild-type P2X2.
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that the MTSET had not been degraded, we used H213C,
which had previously been shown to be accessible to
MTSET. For H213C, MTSET treatment produced a signif-
icant decrease in potentiation as expected. Of the cysteine-
substituted potentiation candidates, the zinc potentiation
before and after MTSET treatment was significantly different
for only D136C (Fig. 5b and c). The other cysteine-
substituted mutants showed potentiation ratios similar to
levels observed before MTSET treatment (Fig. 5c). These
results show that position 136 is accessible to MTSET, and
therefore meets an essential criterion for participation in a
site coordinating extracellular zinc.
Because oocytes expressing the E115A mutant showed
modest zinc potentiation, the failure to see any zinc
potentiation in oocytes expressing E115C was unexpected.
One possible explanation for this result is a cysteine at this
site is unable to engage in zinc binding because it has been
trapped in an unnatural disulfide bond with one of the 10
endogenous cysteines of the extracellular domain of P2X2.
To test this possibility, we treated oocytes expressing E115C
with the reducing agent dithiothreitol (DTT), and then
retested for zinc potentiation. It had previously been
demonstrated that DTT has no effect on zinc potentiation
in wild-type oocytes, but that receptors that carry cysteines
replacing both of the histidines required for zinc potentiation
(H120C/H213C) form disulfide bonds that make them zinc
resistant until after DTT treatment (Nagaya et al. 2005).
Treatment of oocytes expressing E115C with DTT (10 mM
for 5 min) caused no significant increase in potentiation to
20 lM zinc (before )0.6 ± 0.1, after )0.4 ± 0.1; n = 3),
while DTT caused a robust and highly significant increase in
the positive control oocytes expressing the H120C/H213C
double mutant (before 0.1 ± 0.1, after 2.4 ± 0.4; n = 3;
p < 0.001). As the failure of E115C to allow zinc potenti-
ation did not appear to be caused by trapping the cysteine in a
disulfide bond, we considered the possibility that the absence
of a negative charge at position 115 forced the receptor into a
new conformation that either indirectly eliminated the zinc-
binding site, or prevented bound zinc from modifying
channel gating. To test these possibilities, we treated oocytes
expressing E115C with MTSES, a negatively charged
cysteine reactive reagent (Fig. 6). In contrast to the slight
zinc inhibition shown before treatment (which gave negative
zinc potentiation of )0.4 ± 0.1), MTSES-treated oocytes
expressing E115C showed pronounced potentiation to
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Fig. 5 Zinc potentiation in mutants with cysteines at candidate zinc-
binding site locations. (a) Potentiation to 20 lM zinc when an alanine
or a cysteine was substituted at each indicated position. Each bar
represents the average zinc potentiation (as defined in Experimental
procedures) of 4–9 oocytes for each construct assayed. White bars
represent alanine mutants, gray bars represent cysteine mutants, and
error bars represent SEM. The dashed line represents the mean
potentiation for wild-type. The data for the alanine mutants are the
same as shown in Fig. 3. Asterisks indicate when the A and C mutants
at the same position were significantly different (p < 0.01). (b) Rep-
resentative traces for wild-type, H213C, and D136C expressing oo-
cytes before and after MTSET treatment. Zinc potentiation was
present in the untreated H213C mutant, but was greatly reduced fol-
lowing a 1 min exposure to 1 mM MTSET. The dashed lines illustrate
the expected amplitude of the current if MTSET did not interfere with
zinc responses. (c) Results from the MTSET experiments performed
on potentiation candidates shown as the mean potentiation before
MTSET treatment (gray bars) and the mean potentiation after
treatment (white bars). Only the potentiated responses of oocytes
expressing D136C and the H213C positive controls were significantly
(p < 0.01) reduced by MTSET treatment (asterisks). Error bars rep-
resent SEM for 3–7 oocytes per construct.
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tiation after MTSES treatment was a consequence of both a
significant decrease in the response to low ATP alone (to
18 ± 3% of its previous amplitude) and an increase in the
response to ATP plus 20 lM zinc (to 166 ± 28% of its
previous amplitude) with relatively little change in the
response to a high concentration (2 mM) of ATP (85 ± 3%;
n = 6 for each). The effect on E115C was specific for a
negatively charged reagent, as treatment with positively
charged MTSET had no effect on zinc potentiation on
oocytes expressing E115C (potentiation before = )0.5 ±
0.1; potentiation after = )0.2 ± 0.3). However, MTSET
treatment decreased the amplitude of currents in response
to low ATP (to 19 ± 5%) and the currents in response to
2 mM ATP (to 85 ± 8%; n = 5), which were very similar to
the effects of MTSES treatment on these parameters. There
was no significant effect of MTSES treatment on the zinc
potentiation of oocytes expressing wild-type P2X2.
The currents from oocytes expressing the E84C mutant
showed several unexpected features (Fig. 7a). Like wild-type
and the E84A mutant (Fig. 5a), the response of E84C to an
EC10 concentration of ATP plus 20 lM zinc resulted in
substantial zinc potentiation. However, a large component of
this potentiation was only transient, while in wild-type and
E84A it was sustained. Furthermore, the steady-state
responses to low ATP plus 20 lM zinc or 1000 lM zinc
were quite similar in E84C, while in wild-type and E84A the
currents were much smaller in high zinc. MTSET treatment
of individual oocytes expressing E84C resulted in little or no
change in the responses to low ATP alone or to low ATP plus
20 lM zinc (Fig. 7a), but the steady state inhibition by
1000 lM zinc was substantially enhanced (Fig. 7a and b).
MTSET treatment of oocytes expressing E84C also attenu-
ated the current evoked by 1000 lM ATP alone (from
9900nA ± 1100 to 6800 nA ± 700, n = 5).
Discussion
The goal of this study was to test whether any of the
negatively charged residues in the extracellular domain of
P2X2 might directly contribute to zinc binding. As an initial
test of this idea, we made alanine mutations at all 34
extracellular positions at which either a glutamate or an
aspartate was present, characterized the concentration
response relation to ATP of each mutant and then carried
out assays for zinc potentiation and zinc inhibition.
General effects of mutation of negatively charged residues
of P2X2
When the sequences of the seven rat P2X receptors are
compared, 7 of the 34 positions we tested have negatively
charged residues only in P2X2. Of the remaining positions
tested, sixteen have a negatively charged residue in two to
four subunits, three have a negatively charged residue in five
or six subunits, and eight have a negatively charged residue
in all seven subunits (Table 1). When alanine was substituted
at each of the 23 negatively charged positions that are not
highly conserved, there were only modest changes in the
concentration response relations for ATP. Similarly, although
conservation between multiple members of a gene family
often indicates that a residue plays an essential role, we
found only modest changes in the concentration response
relations for ATP when the 11 most highly conserved
residues were replaced with alanines. This agrees with
previous work on all of the homologous residues in human
P2X1 (Ennion et al. 2001) and many of the same residues in
rat P2X2 (Jiang et al. 2000). Similar to the previous work,
the mutants with the most distinctive phenotypes in our study
were E85A and D315A (which are equivalent to D89A and
D316A in human P2X1). In oocytes, both the P2X1 D89A
and the P2X2 E85A mutants produce a modest rightward
shift in ATP potency. A previous attempt to express P2X2
E85A and D261A in HEK293 cells resulted in no detectable
current (Jiang et al. 2000). Perhaps, the ability to express
very high levels of protein in oocytes accounted for our
ability to observe currents from these mutants. In all three
studies, the most left-shifted mutant of the 11 conserved
extracellular acidic residues was produced by placing an
alanine at the position equivalent to D315 of rat P2X2. All
changes at this position are not equivalent, as mutation to
valine by Nakazawa et al. (1998) resulted in a 60-fold
decrease in ATP potency. In summary, neither the conserved
50 µM ATP










Fig. 6 Effect of 20 lM zinc on oocytes expressing E115C before and
after treatment with disulfide reactive reagents. Following the initial
test for responses to ATP and zinc, each oocyte was incubated for
2 min in 10 mM of the indicated reagent and then washed for 1 min
(arrow) before being retested. (a) MTSES restored zinc potentiation.
(b) MTSET did not restore zinc potentiation.
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nor the unconserved negative residues of the extracellular
domain could be demonstrated to play an essential direct role
in allowing P2X2 receptors to respond to ATP. This stands in
stark contrast to the dramatic effect on the EC50 caused by
mutating some of the conserved positive residues of P2X
receptors (Ennion et al. 2000; Jiang et al. 2000).
Are any negatively charged resides involved in binding zinc?
If a residue is required for binding zinc to the potentiating
site, our expectation was that when the residue was replaced
with an alanine the enhancement of ATP-evoked currents by
20 lM zinc would be substantially attenuated. Of the 34
positions tested in our alanine scan, seven (D82, E85, E91,
E115, D136, D209, and D281) showed substantial attenua-
tion of zinc potentiation, although all showed normal pH
potentiation. Similarly, if a residue was required for binding
to the inhibitory site, then the attenuation of ATP-evoked
currents in the presence of 1000 lM zinc would be
significantly lessened. Only one mutant, E84A, passed this
preliminary test. Each of these eight candidate residues was
subjected to a secondary screen which involved producing
mutants that carried a cysteine at each site under study and
then testing the effect of MTSET on zinc modulation. The
rationale for this approach was that if the candidate residue is
part of the zinc-binding site, modification with a bulky
compound like MTSET should occlude the site, and weaken
zinc binding.
The candidate for participation in the inhibitory zinc-
binding site, E84, can be ruled out as a participant in zinc-
binding, because MTSET treatment of oocytes expressing
E84C resulted in greater zinc inhibition. If position 84
contributed directly to zinc-binding at the inhibitory site, less
zinc inhibition would be the expected result. It was also
noted that zinc inhibition was significantly enhanced when
alanine was placed in eight positions. Because the zinc
concentration response relations for potentiation and inhibi-
tion overlap (Clyne et al. 2002a), it was not a surprise that
some mutations that depressed zinc potentiation (E85A,
E91A, E115A, and D136A) showed enhanced inhibition, as
no change to the inhibitory process would be needed to
obtain this result. It is unclear how mutations D127A,
E167A, D172A and D261A enhanced inhibition while
producing no significant reduction of potentiation. It was
not surprising that the E84A mutation, which had a decreased
ability to produce inhibition to high zinc did not result in
enhanced potentiation to 20 lM zinc, because very little
inhibition is produced in wild-type oocytes by 20 lM zinc
(Clyne et al. 2002a).
Of the seven candidates for participation in the potenti-
ating site, only D136C showed significant attenuation of zinc
potentiation following MTSET treatment. However, even
when the MTSET effect had reached saturation (as deter-
mined by a failure to change when the duration of MTSET
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Fig. 7 MTSET sensitivity of zinc inhibition
in oocytes expressing E84C. (a) Repre-
sentative traces for E84C before and after
treatment with 1 mM MTSET. Shown are
responses to low ATP, low ATP with 20 lM
zinc, low ATP with 1000 lM zinc, and
1000 lM ATP. (b) Histogram representing
the average percent inhibition of responses
of E84A (n = 4), and E84C before and after
treatment with MTSET (n = 6). Error bars
represent the SEM. The dashed line rep-
resents the average percent inhibition for
wild-type P2X2 (76 ± 3%, n = 6) stimulated
with low ATP containing 1000 lM zinc.
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mained after MTSET treatment. Like the modification of
D136C we report here, MTSET modification of H120C and
H213C, residues known to be in the zinc-binding site,
produces only attenuation and not elimination of zinc
potentiation. One potential explanation is that although
P2X2 receptors are homotrimers with three zinc-binding sites
producing potentiation, it may not be possible to simulta-
neously modify all three zinc-binding sites with MTSET. If
this is so, residual zinc potentiation would be expected after
MTSET treatment, because it was previously demonstrated
that even a single zinc-binding site is sufficient to produce
substantial potentiation (Nagaya et al. 2005).
Of the other six candidates for involvement in zinc binding
to the excitatory site, the cysteine mutant E115C did not
potentiate to zinc. Additional experiments revealed that it is
unlikely that E115 is in the potentiating zinc-binding site, as
MTSES treatment restored the ability to respond to zinc,
while attaching such a large molecule to a cysteine in the
zinc-binding site would have been expected to occlude zinc
binding. There are two possible explanations why the
cysteine mutants of the other five candidates did not have
altered responses to zinc following MTSET treatment. A
simple one is that MTSET bound to the cysteine, but had no
effect because the candidate residue was not near the zinc-
binding site. An alternative is that one or more of these
residues are part of the excitatory zinc-binding site, but
MTSET was not able to access the cysteine replacing the
endogenous residue. This second explanation seems unlikely
because we know that MTSET can access cysteines replacing
the two histidines (H120 or H213) that are known to be part
of the zinc-binding site (Nagaya et al. 2005). If these six
candidates are not direct participants in zinc binding, what
else might have caused alanine mutations at these sites to
attenuate zinc potentiation? A plausible idea is that these
negative charges are essential for the normal execution of the
conformational changes that follow zinc binding, but not for
opening the channel in response to ATP alone, or to
potentiation by acidic pH, both of which are relatively
normal in these mutants.
If D136 proves to be part of the excitatory zinc-binding
site, then one additional residue likely remains to be
discovered, as most zinc sites are tetrahedral, and two
histidines had previously been identified as participating in
zinc binding. It is potentially of interest that the position
equivalent to D136 is also negatively charged in P2X1, P2X4,
and P2X7. P2X4 is able to potentiate in response to zinc
(Wildman et al. 1999a; Xiong et al. 1999), while P2X1 and
P2X7 are inhibited by zinc (Virginio et al. 1997; Wildman
et al. 1999b). None of these subunits contain histidines at
positions equivalent to H120 or H213 of P2X2, so if the
aspartate equivalent to D136 plays a role in zinc potentiation
in P2X4, one would have to look elsewhere in the sequence
of this subunit for the rest of the excitatory binding site.
Similarly, if E84 proves to be involved in binding zinc at the
inhibitory site of P2X2, one would have to seek a different
site to explain zinc inhibition of P2X1 and P2X7, as a
negative residue is not found at the equivalent position in
these subunits (nor in any subunit other than P2X2).
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